A hidden blockbuster drug for Alzheimer’s disease?
How, you might ask, can a company withhold information about a drug that could potentially prevent such a devastating disease?
#47 – Matthew Walker, Ph.D., on sleep – Part I of III: Dangers of poor sleep, Alzheimer’s risk, mental health, memory consolidation, and more
“I think that sleep may be one of the most significant lifestyle factors that determines your risk ratio for Alzheimer’s disease.” — Matthew Walker
#42 – Avrum Bluming, M.D. and Carol Tavris, Ph.D.: Controversial topic affecting all women—the role of hormone replacement therapy through menopause and beyond—the compelling case for long-term HRT and dispelling the myth that it causes breast cancer
“We welcome the criticism and the discussion, that way we will all learn. We don’t claim to have the final answer, but we think that this book [Estrogen Matters] represents an important step forward in empowering women and helping them live longer and live better.” —Avrum Bluming
#38 – Francisco Gonzalez-Lima, Ph.D.: Advancing Alzheimer’s disease treatment and prevention – is AD actually a vascular and metabolic disease?
“Everybody goes through this cognitive decline. . .this is a reality. . .but it is possible to intervene before you get into the limbic system problems. . . and that’s going to make the biggest difference.” —Francisco Gonzalez-Lima
A radical new approach to Alzheimer’s?
Perhaps a bigger takeaway from this article is the approach this particular group takes: a consortium from different fields converging on the problem is likely the right way to address a problem as daunting as Alzheimer’s disease.
Another name for madness
Alzheimer’s disease often doesn’t just strike one person. Alzheimer’s caregiving is something that might hit us at any time.
#18 – Richard Isaacson, M.D.: Alzheimer’s prevention
“Anyone with a brain is at risk for Alzheimer’s.” —Richard Isaacson
AMA, Alzheimer’s, podcast rec, and NAD rec
Spoiler alert: Not sure taking NAD precursors orally is doing much beyond enriching the companies that make them.
Alzheimer’s prevention and the most important thing
So ironically, while Marks applies these insights to financial investments, many of the same principles apply to the way we should treat our health.
#10 – Matt Kaeberlein, Ph.D.: rapamycin and dogs — man’s best friends? — living longer, healthier lives and turning back the clock on aging and age-related diseases
“I believe that rigorously demonstrating that we can increase healthspan and lifespan in pet dogs will be a huge step toward gaining the support and credibility that the field needs.” —Matt Kaeberlein